Continuous Glucose Monitoring Self-Monitored Blood Glucose Type 2 Therapy Matrix Definition

Completed

Conditions studied: Diabetes Mellitus, Type 2, Diabetic Blood Glucose Monitoring

In brief

The purpose of this study is to use data from the Continuous Glucose Monitoring (CGM) device and your Self-Monitored Blood Glucose (SMBG) levels to determine the best times to test blood glucose levels using SMBG.

Key facts

Study ID

NCT01390610

Run by

HealthPartners Institute

People needed

27

Starts

2011-06-01

Expected to finish

2013-01-01

Last updated by the study team

2015-11-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female
• Diagnosed with type 2 diabetes and treated with diabetes medication(s) as required by the protocol (See Section 3.1)
• Age 18 and older
• Willing to give informed consent
• Motivated and capable of following the protocol and instructions provided by the healthcare professional
• Available for the study on the scheduled visit days
• Have not participated in a prior research trial at IDC that utilized CGM

You may not qualify if…

• Under 18 years of age
• Skin abnormalities at the CGM insertion sites that would confound assessment of the effect of the device on the skin
• Allergy to adhesives
• Taken prednisone or cortisone medications in the previous 30 days
• Currently pregnant or planning pregnancy during the study period
• Presence of any severe medical or psychological condition or chronic conditions/infections that in the opinion of the Investigator would compromise the subject's safety or successful participation in the study
• Unable to follow the study protocol
• Unable to speak, read and write in English

Where it is running

• International Diabetes Center — Minneapolis, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.